Mustang Bio
MBIO
60 hedge funds and large institutions have $4.72M invested in Mustang Bio in 2022 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 5 increasing their positions, 22 reducing their positions, and 15 closing their positions.
0% less ownership
Funds ownership: 0.02% → 0.01% (-0%)
10% less funds holding
Funds holding: 67 → 60 (-7)
31% less capital invested
Capital invested by funds: $6.8M → $4.72M (-$2.09M)
33% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 15
77% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 22
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HighTower Advisors
Chicago,
Illinois
|
+$133K |
| 2 |
Jane Street
New York
|
+$64.5K |
| 3 |
VF
Virtu Financial
New York
|
+$18.4K |
| 4 |
TLP
Tri Locum Partners
New York
|
+$15K |
| 5 |
MCM
MAI Capital Management
Independence,
Ohio
|
+$9.22K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$325K |
| 2 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$262K |
| 3 |
E
Ergoteles
New York
|
-$115K |
| 4 |
Two Sigma Advisers
New York
|
-$66.3K |
| 5 |
Renaissance Technologies
New York
|
-$63.2K |
MBIO Hedge Fund Activity: Q4 2022 in Review
60 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Mustang Bio (MBIO) for Q4 2022, worth a combined $4.72M — down 31% from $6.8M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of MBIO and 10 opened new positions — a net loss of 5 holders — while 22 trimmed existing stakes and 5 added.
The largest buyer was HighTower Advisors, opening a new position worth an estimated $133K. The largest seller was BlackRock, cutting an estimated $325K.
- 60 institutional investors held Mustang Bio (MBIO) as of Q4 2022, down from 67 in Q3 2022.
- Funds reported $4.72M of Mustang Bio stock for Q4 2022, down 31% quarter-over-quarter.
- 10 funds opened new Mustang Bio positions in Q4 2022 and 15 closed out, a net change of -5 holders.
- The largest Mustang Bio buyer in Q4 2022 was HighTower Advisors, an estimated $133K added.
- The largest Mustang Bio seller in Q4 2022 was BlackRock, an estimated $325K sold.
Based on aggregated 13F filings for Q4 2022.